Sun Pharma and some members of its senior leadership have settled a case pertaining to related party transactions and compliance deviations raised in whistleblower complaints in India.

90%-95% of specialty doctors are back at their clinics in India and pharma field force personnel are again on the move, though patient footfall is yet to fully normalize, the country’s largest drug firm Sun has indicated. While the situation isn’t quite the same in the US, the company reported sales growth in both key geographies in Q3.

90-95% of specialty doctors are back at their clinics in India and pharma field force personnel are again on the move, though patient footfall is yet to fully normalize, the country’s largest drug firm Sun has indicated. While the situation isn’t quite the same in the US, the company reported sales growth in both key geographies in Q3.

FDA records show more than 350,000 tubes of clotrimazole anti-fungal topicals made by Taro's US business for private label and store brands were found with a degradation impurity. An Indiana firm is recalling nutritional supplements and pharmaceuticals it supplied to a wellness center owned by the same person due to “concerns with production processes which cannot assure sterility of products.”